Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Masato Yamadera"'
Publikováno v:
Journal of Surgical Case Reports. 2022
Endometriosis is characterized by the presence of an ectopic endometrial gland. Intestinal endometriosis with small bowel obstruction is uncommon. In this case, a 37-year-old woman with no history of endometriosis presented with a chief complaint of
Autor:
Masato Yamadera, Eiji Shinto, Yoji Kishi, Takehiro Shiraishi, Koichi Okamoto, Satsuki Mochizuki, Takahiro Einama, Hitoshi Tsuda, Hideki Ueno, Ken Nagata, Yoshiki Kajiwara
Publikováno v:
Oncotarget
Mesothelin (MSLN) is a cell surface glycoprotein that is normally expressed in the mesothelial cells but highly expressed in several malignant tumors, where the high expression is generally associated with poor prognosis. In this work, 512 patients w
Autor:
Yoji Kishi, Hideki Ueno, Takehiro Shiraishi, Koichi Okamoto, Yoshiki Kajiwara, Satsuki Mochizuki, Eiji Shinto, Masato Yamadera, Kazuo Hase, Ken Nagata
Publikováno v:
BJS Open, Vol 4, Iss 4, Pp 693-703 (2020)
BJS Open
BJS Open
Background Tumour budding is an important prognostic feature in early‐stage colorectal cancer, but its prognostic significance in metastatic disease has not been fully investigated. Methods Patients with stage IV disease who had primary colorectal
Autor:
Hitoshi Tsuda, Hideki Ueno, Eiji Shinto, Takehiro Shiraishi, Kazuo Hase, Koichi Okamoto, Yuichiro Yoshida, Masato Yamadera, Ken Nagata, Satsuki Mochizuki, Yoshiki Kajiwara, Yoji Kishi
Publikováno v:
Annals of Surgical Oncology. 27:4044-4054
Tumor budding, a microscopic finding of dedifferentiation at the invasive margin, has been reported as a definite prognostic marker in colon cancer (CC). Herein, we aimed to generate a molecular budding signature (MBS) based on DNA microarray data an
Autor:
Masato Yamadera, Eiji Shinto, Ken Nagata, Takehiro Shiraishi, Yoshiki Kajiwara, Satsuki Mochizuki, Koichi Okamoto, Yoji Kishi, Hideki Ueno
Publikováno v:
International journal of clinical oncology. 27(4)
In colorectal cancer, tumor budding is highlighted as both a prognostic indicator and a predictor of chemosensitivity. However, tumor budding has a serious drawback because of unattainable preoperative assessment, thereby, making it not applicable to
Autor:
Masato Yamadera, Hideki Ueno, Kazuo Hase, Koichi Okamoto, Hideyuki Shimazaki, Eiji Shinto, Yoshiki Kajiwara, Satsuki Mochizuki
Publikováno v:
Histopathology. 74:1005-1013
Aims The aim of this study was to clarify the quantitative and qualitative differences in tumour budding identification between haematoxylin and eosin (H&E) staining and immunohistochemical (IHC) staining for cytokeratin, and to estimate the respecti
Autor:
Satsuki Mochizuki, Masato Yamadera, Eiji Shinto, Koichi Okamoto, Yoshiki Kajiwara, Keisuke Yonemura, Kentaro Yamada, Hideki Ueno, Tadakazu Ao
Publikováno v:
Surgery Today. 49:629-636
Cancer-induced spiculation (CIS) on computed tomography, which is reticular or linear opacification of the pericolorectal fat tissues around the cancer site, is generally regarded as cancer infiltration into T3 or T4, but its clinicopathological sign
Autor:
Hideki Ueno, Satsuki Mochizuki, Yoji Kishi, Masato Yamadera, Eiji Shinto, Yoshiki Kajiwara, Ken Nagata, Takahiro Einama, Takehiro Shiraishi, Koichi Okamoto
Publikováno v:
Annals of surgical oncology. 28(13)
Mesothelin (MSLN) is a cell-surface glycoprotein present on mesothelial cells; its expression in several epithelial cancers generally portends an unfavorable prognosis. We investigated MSLN as a surrogate chemopredictive biomarker and examined the im
Autor:
Tadakazu Ao, Hideki Ueno, Junji Yamamoto, Keisuke Yonemura, Ken Nagata, Yoshiki Kajiwara, Takehiro Shiraishi, Tomoki Watanabe, Eiji Shinto, Masato Yamadera
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 52:67-75
Autor:
Takehiro Shiraishi, Takahiro Einama, Yoji Kishi, Satsuki Mochizuki, Koichi Okamoto, Hideki Ueno, Masato Yamadera, Ken Nagata, Yoshiki Kajiwara, Eiji Shinto
Publikováno v:
Annals of Surgical Oncology. 28:617-617